Stock listing

ORX Stock Price, News, Filings & Events — Orexo Ab

Selected listing: ORX · OMXSTO · SEK · SE

This page tracks Orexo Ab's ORX:OMXSTO listing on OMXSTO in SEK for SE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ORX:OMXSTO. ORX:OMXSTO is the stock-level entry point for investors researching Orexo Ab, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Orexo Ab is a public company listed on the Swedish market under the ticker ORX, with a market capitalization of approximately 64.9 million USD. The company focuses on developing and commercializing pharmaceutical products. Orexo aims to address unmet medical needs through innovative solutions in the healthcare sector.

ORX:OMXSTOSEKSEUpdated August 29, 2026
Orexo Ab logo
Ticker
ORX:OMXSTO
Asset type
Stock
Market cap
$47.9M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
OMXSTO
Currency
SEK

Orexo Ab ORX:OMXSTO stock context

This page tracks Orexo Ab's ORX:OMXSTO listing on OMXSTO in SEK for SE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ORX:OMXSTO. ORX:OMXSTO is the stock-level entry point for investors researching Orexo Ab, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Orexo Ab is a public company listed on the Swedish market under the ticker ORX, with a market capitalization of approximately 64.9 million USD. The company focuses on developing and commercializing pharmaceutical products. Orexo aims to address unmet medical needs through innovative solutions in the healthcare sector.

Latest news from Orexo Ab

All Orexo Ab news →

Orexo Ab earnings calls

Research Orexo Ab

Alternate listings